Net Cash Provided by (Used in) Operating Activities of Vitro Biopharma, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
Vitro Biopharma, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
  • Vitro Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Jan 2025 was $428,336, a 64% increase year-over-year.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $2,537,843, a 22% increase from 2024.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $3,236,339, a 64% decline from 2023.
  • Vitro Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $1,968,835, a 11% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $2,537,843 +$698,496 +22% 01 Nov 2024 31 Oct 2025 10-K 13 Feb 2026 2025 FY
2024 $3,236,339 -$1,267,504 -64% 01 Nov 2023 31 Oct 2024 10-K 13 Feb 2026 2025 FY
2023 $1,968,835 +$247,785 +11% 01 Nov 2022 31 Oct 2023 10-K 28 Jan 2025 2024 FY
2022 $2,216,620 01 Nov 2021 31 Oct 2022 10-K 29 Jan 2024 2023 FY
2015 $100,403 +$19,575 +16% 01 Nov 2014 31 Oct 2015 10-K 22 Sep 2016 2015 FY
2014 $119,978 -$12,443 -12% 01 Nov 2013 31 Oct 2014 10-K 22 Sep 2016 2015 FY
2013 $107,535 +$23,094 +18% 01 Nov 2012 31 Oct 2013 10-K 13 Feb 2015 2014 FY
2012 $130,629 -$14,779 -13% 01 Nov 2011 31 Oct 2012 10-K 12 Feb 2014 2013 FY
2011 $115,850 +$7,600 +6.2% 01 Nov 2010 31 Oct 2011 10-K 12 Feb 2013 2012 FY
2010 $123,450 01 Nov 2009 31 Oct 2010 10-K/A 16 Feb 2012 2011 FY

Vitro Biopharma, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $428,336 +$771,825 +64% 01 Nov 2024 31 Jan 2025 10-Q 20 Mar 2025 2025 Q1
Q4 2023 $1,200,161 -$250,303 -26% 01 Nov 2023 31 Jan 2024 10-Q 20 Mar 2025 2025 Q1
Q4 2022 $949,858 -$191,442 -25% 01 Nov 2022 31 Jan 2023 10-Q 14 Mar 2024 2024 Q1
Q4 2021 $758,416 01 Nov 2021 31 Jan 2022 10-Q 14 Mar 2023 2023 Q1
Q4 2014 $23,719 +$16,315 +41% 01 Nov 2014 31 Jan 2015 10-Q 24 Mar 2015 2015 Q1
Q4 2013 $40,034 +$8,623 +18% 01 Nov 2013 31 Jan 2014 10-Q 24 Mar 2015 2015 Q1
Q4 2012 $48,657 +$7,042 +13% 01 Nov 2012 31 Jan 2013 10-Q 21 Mar 2013 2013 Q1
Q4 2011 $55,699 -$1,130 -2.1% 01 Nov 2011 31 Jan 2012 10-Q 21 Mar 2013 2013 Q1
Q4 2010 $54,569 01 Nov 2010 31 Jan 2011 10-Q 21 Mar 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.